These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 21262808)

  • 1. Cognitive dysfunction and prefrontal synaptic abnormalities in a mouse model of fragile X syndrome.
    Krueger DD; Osterweil EK; Chen SP; Tye LD; Bear MF
    Proc Natl Acad Sci U S A; 2011 Feb; 108(6):2587-92. PubMed ID: 21262808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7, 8-Dihydroxyflavone induces synapse expression of AMPA GluA1 and ameliorates cognitive and spine abnormalities in a mouse model of fragile X syndrome.
    Tian M; Zeng Y; Hu Y; Yuan X; Liu S; Li J; Lu P; Sun Y; Gao L; Fu D; Li Y; Wang S; McClintock SM
    Neuropharmacology; 2015 Feb; 89():43-53. PubMed ID: 25229717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome profiling of the prefrontal cortex of Fmr1 knockout mouse reveals enhancement of complement and coagulation cascades.
    Gao MM; Shi H; Yan HJ; Long YS
    J Proteomics; 2023 Mar; 274():104822. PubMed ID: 36646274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo.
    Higashimori H; Schin CS; Chiang MS; Morel L; Shoneye TA; Nelson DL; Yang Y
    J Neurosci; 2016 Jul; 36(27):7079-94. PubMed ID: 27383586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ICAM5 as a Novel Target for Treating Cognitive Impairment in Fragile X Syndrome.
    Pei YP; Wang YY; Liu D; Lei HY; Yang ZH; Zhang ZW; Han M; Cheng K; Chen YS; Li JQ; Cheng GR; Xu L; Wu QM; McClintock SM; Yang Y; Zhang Y; Zeng Y
    J Neurosci; 2020 Feb; 40(6):1355-1365. PubMed ID: 31882402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic minocycline treatment improves social recognition memory in adult male Fmr1 knockout mice.
    Yau SY; Chiu C; Vetrici M; Christie BR
    Behav Brain Res; 2016 Oct; 312():77-83. PubMed ID: 27291517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocytic Contributions to Synaptic and Learning Abnormalities in a Mouse Model of Fragile X Syndrome.
    Hodges JL; Yu X; Gilmore A; Bennett H; Tjia M; Perna JF; Chen CC; Li X; Lu J; Zuo Y
    Biol Psychiatry; 2017 Jul; 82(2):139-149. PubMed ID: 27865451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-9 deletion rescues auditory evoked potential habituation deficit in a mouse model of Fragile X Syndrome.
    Lovelace JW; Wen TH; Reinhard S; Hsu MS; Sidhu H; Ethell IM; Binder DK; Razak KA
    Neurobiol Dis; 2016 May; 89():126-35. PubMed ID: 26850918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of autophagy rescues synaptic and cognitive deficits in fragile X mice.
    Yan J; Porch MW; Court-Vazquez B; Bennett MVL; Zukin RS
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):E9707-E9716. PubMed ID: 30242133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in CA1 hippocampal synapses in a mouse model of fragile X syndrome.
    Jawaid S; Kidd GJ; Wang J; Swetlik C; Dutta R; Trapp BD
    Glia; 2018 Apr; 66(4):789-800. PubMed ID: 29274095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fragile X-like behaviors and abnormal cortical dendritic spines in cytoplasmic FMR1-interacting protein 2-mutant mice.
    Han K; Chen H; Gennarino VA; Richman R; Lu HC; Zoghbi HY
    Hum Mol Genet; 2015 Apr; 24(7):1813-23. PubMed ID: 25432536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fragile X mental retardation protein in learning-related synaptic plasticity.
    Mercaldo V; Descalzi G; Zhuo M
    Mol Cells; 2009 Dec; 28(6):501-7. PubMed ID: 20047076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Object recognition impairment in Fmr1 knockout mice is reversed by amphetamine: involvement of dopamine in the medial prefrontal cortex.
    Ventura R; Pascucci T; Catania MV; Musumeci SA; Puglisi-Allegra S
    Behav Pharmacol; 2004 Sep; 15(5-6):433-42. PubMed ID: 15343070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased surface expression of the δ subunit of the GABA
    Zhang N; Peng Z; Tong X; Lindemeyer AK; Cetina Y; Huang CS; Olsen RW; Otis TS; Houser CR
    Exp Neurol; 2017 Nov; 297():168-178. PubMed ID: 28822839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fragile X mental retardation protein replacement restores hippocampal synaptic function in a mouse model of fragile X syndrome.
    Zeier Z; Kumar A; Bodhinathan K; Feller JA; Foster TC; Bloom DC
    Gene Ther; 2009 Sep; 16(9):1122-9. PubMed ID: 19571888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-Dependent Long-Term Potentiation Deficits in the Prefrontal Cortex of the Fmr1 Knockout Mouse Model of Fragile X Syndrome.
    Martin HGS; Lassalle O; Brown JT; Manzoni OJ
    Cereb Cortex; 2016 May; 26(5):2084-2092. PubMed ID: 25750254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BDNF in fragile X syndrome.
    Castrén ML; Castrén E
    Neuropharmacology; 2014 Jan; 76 Pt C():729-36. PubMed ID: 23727436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic metabotropic glutamate receptor 5 inhibition corrects local alterations of brain activity and improves cognitive performance in fragile X mice.
    Michalon A; Bruns A; Risterucci C; Honer M; Ballard TM; Ozmen L; Jaeschke G; Wettstein JG; von Kienlin M; Künnecke B; Lindemann L
    Biol Psychiatry; 2014 Feb; 75(3):189-97. PubMed ID: 23910948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of an mGluR5 inhibitor on procedural memory and avoidance discrimination impairments in Fmr1 KO mice.
    Vinueza Veloz MF; Buijsen RA; Willemsen R; Cupido A; Bosman LW; Koekkoek SK; Potters JW; Oostra BA; De Zeeuw CI
    Genes Brain Behav; 2012 Apr; 11(3):325-31. PubMed ID: 22257369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral abnormalities in the Fmr1-KO2 mouse model of fragile X syndrome: The relevance of early life phases.
    Gaudissard J; Ginger M; Premoli M; Memo M; Frick A; Pietropaolo S
    Autism Res; 2017 Oct; 10(10):1584-1596. PubMed ID: 28590057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.